In Brief This Week: Transgenomic; Fluxion Biosciences; Silicon Biosystems; DNA Genotek; Annai Systems | GenomeWeb

NEW YORK (GenomeWeb News) – Transgenomic said in a document filed with the US Securities and Exchange Commission this week that its shareholders have approved an increase in the number of authorized shares of the firm's common stock from 100 million to 150 million.


Fluxion Biosciences said this week that it has launched its discovery services business, which will offer a range of cellular assays in ion channels using its IonFlux system, functional cell analysis using its BioFlux system, and circulating tumor cell analysis using its IsoFlux platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.